Rx&D

Rx&D
Life Sciences Ontario (LSO)

Life Sciences Ontario (LSO)

October 10, 2013 16:00 ET

Life Sciences Ontario and Rx&D Join Forces to Strengthen Canada's Life Sciences Sector

OTTAWA, ONTARIO--(Marketwired - Oct. 10, 2013) - Life Sciences Ontario (LSO) and Canada's Research-Based Pharmaceutical Companies (Rx&D) have announced an exciting new joint membership initiative for emerging biopharmaceutical companies and associated stakeholders in Ontario. In an effort to enhance networking opportunities and develop partnerships that will lead to the discovery of the next generation of life-saving therapies, qualifying LSO Core Life Sciences members that do not yet generate revenue from product sales and royalties in Canada, and Clinical/Contract Research Organization (CRO) members of LSO, are invited to join Rx&D through a joint membership initiative.

"Our members - including the emerging biopharmaceutical companies and clinical/contract research organizations - play a critical role in the R&D ecosystem," said LSO Executive Director Jason Field on the occasion of the announcement. "They share a common interest in the development and commercialization of innovative medicines and vaccines. This membership opportunity is a great step in connecting the two organizations as we work to make Canada the ideal destination for life science R&D investments."

This join initiative provides an opportunity for life science entrepreneurs to benefit from expertise across the broader industry including:

  • Access to well established branding and communications channels;

  • Access to industry leaders with global experience;

  • Access to expertise in government relations, intellectual property, policy development, public affairs, communications, and stakeholder relations; and,

  • Timely information on important, ever-changing issues, developments, legislations and regulations within the biopharmaceutical marketplace through networking and information forums.

"This is yet another great example of our commitment to a new business model focussed on partnerships and collaboration across the country," added Rx&D President Russell Williams. "We've been successful in developing cooperative relationships with partners across Canada's healthcare and life science sectors. This is a natural partnership - Rx&D and LSO share a commitment to help drive a vibrant knowledge-based economy and to the continuous improvement of the health and well-being of Canadians."

About LSO

Life Sciences Ontario (LSO) is a member-driven organization that represents and promotes the province's vibrant and diverse life sciences sector. LSO collaborates with governments, academia, industry and other life science organizations in Ontario and across Canada to promote and encourage commercial success throughout this diverse sector. We do this through advocacy, facilitation of economic development, promotion of our industry locally, nationally and internationally and by bringing life sciences stakeholders together through numerous networking events. LSO is the Voice for Life Sciences in Ontario.

About Rx&D

Rx&D is the association of leading research-based pharmaceutical companies dedicated to improving the health of Canadians through the discovery and development of new medicines and vaccines. Our community represents the men and women working for more than 50 member companies which invest more than $1 billion in research and development each year to fuel Canada's knowledge-based economy, contributing over $3 billion to the Canadian economy. Guided by our Code of Ethical Practices, our membership is committed to working in partnership with governments, private payers, healthcare professionals and stakeholders in a highly ethical manner.

Contact Information